Onconova Therapeutics, Inc. (ONTX) NASDAQ

1.00

-0.0047(-0.47%)

Updated at April 02, 2024 04:00PM

Currency In USD

Valuation

Market Cap10.25M
Enterprise Value-11.09M
P/E Ratio-0.79
PEG Ratio-0.02
Price/Sales Ratio2.12
Price/Book Ratio0.87
Enterprise/Revenue-2.57
Enterprise/EBITDA0.65

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-3.26
Operating Margin-3.51

Management Effectiveness

Return On Assets-0.58
Return On Equity0.78

Income Statement

Revenue226,000
Revenue/Share0.48
Gross Profit0
EBITDA-142.37M
Net Income-1.67M
Diluted EPS-10.72

Balance Sheet

Total Cash6.42B
Total Cash/Share2.25
Total Debt0
Total Debt/Equity0
Current Ratio2.09
Book Value Per Share1.42

Price History

52-Week Change-6.98
52-Week High1.45
52-Week Low0.55
Moving Average 50 Days0.82
Moving Average 200 Days0.78

Statistics

Average Volume126,338
Shares Outstanding21M
% Held by Institutions0

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:15
Last Split DateMay 21, 2021